Navigation Links
Silence Therapeutics Announces Issuance of Japanese Patent for Screening Therapeutics Against Key Pathway Associated with Cancer and Other Diseases
Date:9/16/2011

LONDON, September 16, 2011 /PRNewswire/ --


Silence Therapeutics plc (AIM: SLN) ("Silence" or the "Company"), a leading RNA interference (RNAi) therapeutics company, announces the issuance of patent 4810095 entitled "Use of Protein Kinase N beta" by the Japanese Patent Office. The issued patent covers certain methods for screening a therapeutic agent for the treatment and/or prevention of any disease that involves elevated activity within the PI3-kinase pathway. More specifically, this new intellectual property covers the use of protein kinase N 3 ("PKN3") for screening of therapeutic agents, thus preventing others from using PKN3 for screening purposes. This new patent is broadly directed to various classes of therapeutic agents with the potential to impact the PI3-kinase pathway including short interfering RNA (siRNA) molecules, antibodies and small molecules, among others.  

PKN3 is a protein kinase C-related molecule, involved in the PI3-kinase pathway that is believed to play an important role in the growth of cancer cells, as well as metastasis formation. Silence has built a significant research program around PKN3 and the company's lead clinical compound, Atu027, is an RNAi therapeutic that targets PKN3 for the treatment of advanced solid tumors.  

"We are excited about consolidating our broad patent portfolio in Japan, especially as it pertains to our high-value PKN3 program," said Dr Klaus Giese, chief scientific officer of Silence Therapeutics. "This patent positions Silence as the exclusive gatekeeper for any project focused on developing therapeutics targeting PKN3, and as interest in this important oncology target continues to grow rapidly, we expect the value of this intellectual property position will also increase significantly."

Silence Therapeutics is proactively building and strengthening its global, diverse and competitive intellectual property portfolio. This provides the Company and po
'/>"/>

SOURCE Silence Therapeutics Plc
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine technology :

1. Silence Therapeutics and InteRNA Technologies Sign Collaboration to Develop Novel microRNA Therapeutics
2. Silence Therapeutics Receives Notice of Allowance for New U.S. Patent Covering Novel Small Interfering RNA (siRNA) Delivery Technology
3. Silence Therapeutics Phase I Atu027 Data Accepted for Presentation at the American Society of Clinical Oncology 2011 Annual Meeting
4. Silence Therapeutics Issued New U.S. Patent Covering Fundamental RNA Interference Technology Currently in Several Clinical Trials
5. Silence Therapeutics Provides Year-end Update
6. Silence Therapeutics Issued New Patents Covering siRNA Sequences for RNA Interference Therapeutics
7. Silence Therapeutics and AstraZeneca Extend siRNA Development Collaboration
8. Silence Therapeutics to Merge with Intradigm Corp to Create Leading RNAi Therapeutics Company
9. Silence Therapeutics to Receive $1.9m Milestone Payment as Pfizer and Quark Commence Phase II Trial
10. Silence Therapeutics Announces Board Changes
11. Recent siRNA Research Publications Support Silence Therapeutics Combined Development Approach
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/14/2014)... , Sept. 14, 2014 /PRNewswire-iReach/ -- "Hematoma Global Clinical ... clinical trial scenario. This report provides elemental information and ... includes an overview of the trial numbers and their ... across the globe. The databook offers a preliminary coverage ... prominence of the sponsors and also provides briefing pertaining ...
(Date:9/14/2014)... , September 14, 2014 Elbit ... EMITF ) announced today further to the Company,s ... (the "Company,s Previous Reports"), that it was informed by ... US$ 12.5 million by  Shanghai GEOC Hengtong Investment Limited ... the framework of the present investment round in InSightec, ...
(Date:9/12/2014)... 2014 In the current outcomes-focused market, ... Health Outcomes Liaison (HOL) staff to serve as ... and other important healthcare decision makers. As the ... successful companies will need to understand how to ... To help organizations identify industry trends ...
Breaking Medicine Technology:Hematoma Therapeutics Clinical Trials Market Overview on Companies, Top Institutes & Clinical Profiles to 2014 2Hematoma Therapeutics Clinical Trials Market Overview on Companies, Top Institutes & Clinical Profiles to 2014 3Hematoma Therapeutics Clinical Trials Market Overview on Companies, Top Institutes & Clinical Profiles to 2014 4Hematoma Therapeutics Clinical Trials Market Overview on Companies, Top Institutes & Clinical Profiles to 2014 5Elbit Imaging Ltd. Announces Investment of US$ 12.5 Million in Insightec by Shanghai GEOC Hengtong Investment Limited Partnership and Fortune China Limited 2Elbit Imaging Ltd. Announces Investment of US$ 12.5 Million in Insightec by Shanghai GEOC Hengtong Investment Limited Partnership and Fortune China Limited 3Pharmaceutical Sector Turning to Health Outcomes Liaisons to Help Industry Navigate Payer-Focused Marketplace 2
(Date:9/14/2014)... 14, 2014 Adults who are planning ... Quotes Pros website to find quotes for life insurance ... year at http://quotespros.com/life-insurance.html is now delivering the ... partners that are preparing the rates information for adults ... most U.S. states. As a way to simplify the ...
(Date:9/14/2014)... York, New York (PRWEB) September 14, 2014 ... ) continue to move forward in courts throughout ... a brief filed in San Francisco Superior Court, ... have asked the judge overseeing the proceeding to ... their cases re-transferred to Los Angeles Superior Court. ...
(Date:9/14/2014)... Top10BestSEOHosting.com always offers truly reliable information ... suppliers carefully, the site has announced that Arvixe ... Best WordPress Hosting suppliers in the current market. ... web hosting provider, and the company’s reputation for ... provider known for its flexible hosting packages, decent ...
(Date:9/14/2014)... 14, 2014 School requires that children read ... that they be screened only for far vision when they ... away. When their eyes do not track effectively or ... will, at best, avoid reading; at worst, they will ... ability to learn. Children who cannot see cannot read. ...
(Date:9/13/2014)... PA (PRWEB) September 13, 2014 “I ... air we breathe, especially in major cities, is quite ... Ancaster, Ontario, Canada. “I thought we deserved a healthier ... they invented THE OXYGENIZER. , THE OXYGENIZER prevents pollutants ... and mouth. In doing so, it provides added peace ...
Breaking Medicine News(10 mins):Health News:Quotes for Life Insurance Now Offered at New Consumer Portal Online 2Health News:DePuy ASR Lawsuit News: Defense Asks Judge Overseeing California Litigation to Deny Opt-Out Plaintiffs’ Re-Transfer Request, Bernstein Liebhard LLP Reports 2Health News:DePuy ASR Lawsuit News: Defense Asks Judge Overseeing California Litigation to Deny Opt-Out Plaintiffs’ Re-Transfer Request, Bernstein Liebhard LLP Reports 3Health News:DePuy ASR Lawsuit News: Defense Asks Judge Overseeing California Litigation to Deny Opt-Out Plaintiffs’ Re-Transfer Request, Bernstein Liebhard LLP Reports 4Health News:Top10BestSEOHosting.com: The Best Linux Web Hosting Suppliers Now Unveiled 2Health News:Personal Air Filtering Device Invented by InventHelp Clients (TOR-9166) 2
... Nov. 11 Ken Herron, Chief Marketing,Executive at ... announced,today that David S. Novak of the Centers ... team at Online Buddies, Inc. as the site,s ... networking site for,gay men, with 2,000,000 members worldwide, ...
... - Global Health,innovator IntraHealth International will participate as ... to improve public health needs in the,West Bank, ... to Washington,DC-based Chemonics International and its subcontractors by ... The new Palestinian Health Sector Reform Project aims ...
... In women, habitual snoring may be an independent ... regardless of sleep apnea occurrences. Researchers from Sweden ... aged 20 to 70 years. The apnea-hypopnea index ... loudly and disturbingly often or very often were ...
... Germany, Nov. 11 Texas Instruments,(NYSE: ... of more than 15 dedicated,embedded processors which ... clinicians while empowering imaging equipment manufacturers to ... smaller and more portable.,These processors target several ...
... his speech today at electronica 2008, Pat O’Doherty, ... spotlighted how sophisticated healthcare semiconductor technology is paving ... and more powerful medical devices for use in ... of devices include those that check glucose levels ...
... 85 Americans die by suicide and hundreds of thousands more ... on suicide have focused on identifying psychiatric risk factors. However, ... published online this month in Social Science and Medicine ... closely analyzing the patterns of suicide in a single geographic ...
Cached Medicine News:Health News:MANHUNT Leads Fight Against Spread of Sexually Transmitted Infections with Launch of MANHUNT Cares; Hires Senior Public Health Strategist from CDC 2Health News:IntraHealth to Support Health Reform in Palestine 2Health News:Journal CHEST: Nov. highlights 2Health News:Video: Medical Imaging Equipment OEMs Can Achieve Faster, More Accurate Results with TI's Portfolio of Embedded Processors and Analog Products 2Health News:Video: Medical Imaging Equipment OEMs Can Achieve Faster, More Accurate Results with TI's Portfolio of Embedded Processors and Analog Products 3Health News:Video: Medical Imaging Equipment OEMs Can Achieve Faster, More Accurate Results with TI's Portfolio of Embedded Processors and Analog Products 4Health News:Video: Medical Imaging Equipment OEMs Can Achieve Faster, More Accurate Results with TI's Portfolio of Embedded Processors and Analog Products 5Health News: Analog Devices Healthcare Director Delivers Speech on Role of Analog Semiconductors in Next-Generation Portable Medical Equipment : ADI's Pat O'Doherty is a featured speaker at electronica 2008. 2Health News: Analog Devices Healthcare Director Delivers Speech on Role of Analog Semiconductors in Next-Generation Portable Medical Equipment : ADI's Pat O'Doherty is a featured speaker at electronica 2008. 3Health News:What happens in Vegas? Place as a risk factor for suicide 2
The Emit 2000 Digoxin Assay is a homogeneous enzyme immunoassay intended for use in the quantitative analysis of digoxin in human serum or plasma. Emit 2000 assays are designed for use with most chem...
Liquichek Rheumatoid Factor Control is a liquid trilevel control designed to monitor rheumatoid factor testing procedures, including nephelometric and latex agglutination methods....
... (Rapid Plasma Reagin) 18-mm Circle Card ... testing procedures for the serological detection ... of Tests for Syphilis.* The test ... most widely used in the United ...
... a non-reactive quality assurance reagent in assays detecting ... IgG and TOXO IgM), IgG and IgM antibodies ... IgG and IgM antibodies to cytomegalovirus (CMV IgG ... herpes simplex virus types 1 and 2 (HSV-1 ...
Medicine Products: